Holen Sie sich die Stockscreener-App
244.15
1.93%
-4.81
Schlusskurs vom Vortag:
$248.96
Offen:
$249.86
24-Stunden-Volumen:
262.70K
Relative Volume:
0.73
Marktkapitalisierung:
$9.41B
Einnahmen:
$1.16B
Nettoeinkommen (Verlust:
$34.55M
KGV:
237.04
EPS:
1.03
Netto-Cashflow:
$134.18M
1W Leistung:
+2.07%
1M Leistung:
+19.27%
6M Leistung:
+26.07%
1J Leistung:
+5.68%
1-Tages-Spanne:
$240.30
$250.81
1-Wochen-Bereich:
$235.93
$250.94
52-Wochen-Spanne:
$148.00
$277.34
Penumbra Inc Stock (PEN) Company Profile
Firmenname
Penumbra Inc
Sektor
Branche
Telefon
(510) 995-2486
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Vergleichen Sie PEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
244.15 | 9.41B | 1.16B | 34.55M | 134.18M | 1.03 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-18 | Eingeleitet | Stifel | Buy |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-31 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-07-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-29 | Herabstufung | Needham | Buy → Hold |
| 2023-01-30 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-09 | Hochstufung | Needham | Hold → Buy |
| 2022-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
| 2022-03-08 | Eingeleitet | Needham | Hold |
| 2021-09-16 | Eingeleitet | Truist | Buy |
| 2021-06-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2020-09-29 | Eingeleitet | BTIG Research | Buy |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Eingeleitet | William Blair | Outperform |
| 2018-10-29 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-10-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-02-21 | Eingeleitet | William Blair | Outperform |
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-13 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Penumbra Inc (PEN) Stock Price Down 3.01% on Nov 27 - GuruFocus.com
Penumbra, Inc. (NYSE:PEN) Shares Sold by Algert Global LLC - MarketBeat
Leerink Partnrs Estimates Penumbra's Q4 Earnings (NYSE:PEN) - MarketBeat
Loomis Sayles & Co. L P Acquires 13,534 Shares of Penumbra, Inc. (NYSE:PEN) - MarketBeat
FY2024 EPS Estimates for Penumbra Raised by Leerink Partnrs - MarketBeat
Massachusetts Financial Services Co. MA Makes New $31.97 Million Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved Technologies - Insider Monkey
PEN (Penumbra) Total Assets : $1,479 Mil (As of Sep. 2024) - GuruFocus.com
PEN (Penumbra) Cyclically Adjusted PB Ratio : 12.96 (As of Nov. 25, 2024) - GuruFocus.com
Penumbra, Inc. (NYSE:PEN) Stock Position Lowered by Intech Investment Management LLC - MarketBeat
Natixis Advisors LLC Has $5.39 Million Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra, Inc. (NYSE:PEN) CEO Adam Elsesser Sells 15,000 Shares - MarketBeat
3 Reasons Growth Investors Will Love Penumbra (PEN) - Yahoo Finance
Penumbra to Present at Piper Sandler Healthcare Conference in December 2024 | PEN Stock News - StockTitan
Penumbra price target raised to $250 from $235 at Piper Sandler - TipRanks
Breaking Down Penumbra: 11 Analysts Share Their Views - Benzinga
Penumbra Secures Innovation Award for Breakthrough Thrombectomy Technologies - Medical Device Network
When the Price of (PEN) Talks, People Listen - Stock Traders Daily
LMR Partners LLP Makes New $2.33 Million Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra, Inc. (NYSE:PEN) Holdings Lifted by Thrivent Financial for Lutherans - MarketBeat
Penumbra, Inc. (PEN): A Bull Case Theory - Insider Monkey
Principal Financial Group Inc. Decreases Stock Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Los Angeles Capital Management LLC Acquires 8,222 Shares of Penumbra, Inc. (NYSE:PEN) - MarketBeat
Baillie Gifford & Co. Has $115 Million Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
SpiderRock Advisors LLC Purchases Shares of 2,645 Penumbra, Inc. (NYSE:PEN) - MarketBeat
Immersive VR Market Analysis 2024-2029 with Meta, Sony, - GlobeNewswire
Analysts Set Penumbra, Inc. (NYSE:PEN) Price Target at $226.67 - MarketBeat
There May Be Some Bright Spots In Penumbra's (NYSE:PEN) Earnings - Yahoo Finance
Intracranial Stents Market Expected to Reach US$ 702.8 Million - openPR
Penumbra reveals positive data for algorithm-assisted thrombectomy tech - Clinical Trials Arena
Here's Why Penumbra (PEN) is a Strong Momentum Stock - MSN
Here is Why Growth Investors Should Buy Penumbra (PEN) Now - Yahoo Finance
Penumbra has positive data for computer-assisted vacuum thrombectomy system - Mass Device
Penumbra reports shorter stays, fewer PE complications with CAVT - Investing.com
Penumbra reports shorter stays, fewer PE complications with CAVT By Investing.com - Investing.com Canada
Penumbra's CAVT Tech Shows 35% Shorter Hospital Stays, 3x Fewer PE Complications | PEN Stock News - StockTitan
AlphaCentric Advisors LLC Buys New Stake in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra's SWOT analysis: innovation drives growth amid market challenges - Investing.com India
Penumbra shares rise as Canaccord lifts target, keeps at Buy list - Investing.com Canada
Implied Volatility Surging for Penumbra (PEN) Stock Options - MSN
Penumbra revenue jumps 11.1% to USD 301M in Q3 2024 - Medical Buyer
William Blair Weighs in on Penumbra's Q1 Earnings (NYSE:PEN) - MarketBeat
Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Yahoo Finance
Is Penumbra, Inc.'s (NYSE:PEN) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Simply Wall St
Penumbra Inc (PEN) Shares Up 3.26% on Nov 1 - GuruFocus.com
Penumbra Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Leerink Partnrs Has Bearish Outlook for Penumbra Q4 Earnings - MarketBeat
Penumbra, Inc. (NYSE:PEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Exploring the Future of Virtual Reality: Market Overview, Trends, Analysis & Key Players - GlobeNewswire Inc.
Penumbra stock maintains buy rating with BTIG despite price target cut - Investing.com India
Penumbra Inc (PEN) Trading 4.48% Higher on Oct 31 - GuruFocus.com
Finanzdaten der Penumbra Inc-Aktie (PEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):